Per Reuters: During his first term, a court blocked his proposed international reference pricing program.
The difference in this term is the admin spices up EO's by flagrantly defying court orders. I don't see how the magic sauce helps here. When a court strikes down this EO, US drug makers carry on as ever. And the admin defies - what?
The difference in this term is the admin spices up EO's by flagrantly defying court orders. I don't see how the magic sauce helps here. When a court strikes down this EO, US drug makers carry on as ever. And the admin defies - what?
https://www.reuters.com/business/healthcare-pharmaceuticals/...